News Wales approves new hepatitis C drug while England deliberates BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6499 (Published 01 December 2016) Cite this as: BMJ 2016;355:i6499 Article Related content Metrics Responses Peer review Related articles Feature A pill too hard to swallow: how the NHS is limiting access to high priced drugs Published: 27 July 2016; BMJ 354 doi:10.1136/bmj.i4117 News NICE approval of new hepatitis drug could result in £700m bill for NHS Published: 21 October 2015; BMJ 351 doi:10.1136/bmj.h5554 See more Physician associates: Parliament was “misadvised” on RCP’s support for regulation, fellows say BMJ September 18, 2024, 386 q2047; DOI: https://doi.org/10.1136/bmj.q2047 Scarlett McNally: Building healthy habits for the new academic year BMJ September 18, 2024, 386 q2013; DOI: https://doi.org/10.1136/bmj.q2013 “Health creation system” could save NHS £18bn a year, says commission BMJ September 18, 2024, 386 q2043; DOI: https://doi.org/10.1136/bmj.q2043 The Darzi review distributes blame effectively BMJ September 17, 2024, 386 q2040; DOI: https://doi.org/10.1136/bmj.q2040 Matt Morgan: Pods and wards—flipping through rotations BMJ September 17, 2024, 386 q2022; DOI: https://doi.org/10.1136/bmj.q2022 Cited by... Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice GuidelineAbstract Fulltext PDF
